ARRAY BIOPHARMA INC 4
4 · ARRAY BIOPHARMA INC · Filed Jul 25, 2013
Insider Transaction Report
Form 4
SNITMAN DAVID
DirectorCOO and VP, Business Devel.
Transactions
- Exercise/Conversion
Common Stock
2013-07-24$3.75/sh+21,357$80,089→ 1,517,509 total - Tax Payment
Common Stock
2013-07-24$6.07/sh−15,151$91,967→ 1,502,358 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-24−21,357→ 0 totalExercise: $3.75Exp: 2013-08-01→ Common Stock (21,357 underlying)
Holdings
- 119,950(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The option vested in four equal annual installments beginning July 1, 2004.